Photon Control Inc. — Regulatory Filings 2021

May 20, 2021

==> picture [222 x 27] intentionally omitted <==

May 19, 2021

Norton Rose Fulbright Canada LLP 510 West Georgia Street, Suite 1800 Vancouver, BC V6B 0M3 Canada

F: +1 604.641.4949 nortonrosefulbright.com

• To: The British Columbia Securities Commission, as principal regulator, on behalf of the securities regulators in each province of Alberta and Ontario

Subject: Prospectus of Brachium2 Capital Corp. dated May 19, 2021

Dear Sirs/Mesdames:

In connection with the final prospectus of Brachium2 Capital Corp. dated May 19, 2021 (the “ Prospectus ”), we consent to the references to our name, Norton Rose Fulbright Canada LLP, under the headings “ Receipt of Subscriptions ” and “ Relationship between the Corporation and Professional Persons ” in the Prospectus, and to the use of our name and legal opinions under the headings “ Eligibility for Investment ” in the Prospectus.

We confirm that we have read the Prospectus and have no reason to believe that there are any misrepresentations in the information contained therein that is derived from our legal opinions or that is within our knowledge as a result of the services we performed in connection with such opinions.

Yours truly,

“Norton Rose Fulbright Canada LLP”

CAN_DMS: \139199653\1

Norton Rose Fulbright Canada LLP is a limited liability partnership established in Canada.

Norton Rose Fulbright Canada LLP, Norton Rose Fulbright LLP, Norton Rose Fulbright Australia, Norton Rose Fulbright South Africa Inc and Norton Rose Fulbright US LLP are separate legal entities and all of them are members of Norton Rose Fulbright Verein, a Swiss verein. Norton Rose Fulbright Verein helps coordinate the activities of the members but does not itself provide legal services to clients. Details of each entity, with certain regulatory information, are at nortonrosefulbright.com.